News Summary:
MILFORD, Mass., and MUNICH, April 9, 2024 /PRNewswire/ -- Analytica 2024 -- Waters Corporation (NYSE:WAT) today announced the launch of the Alliance iS Bio HPLC System with new capabilities that address the operational and analytical challenges of biopharma quality control (QC) laboratories. The new HPLC system combines advanced bio-separation technology and built-in instrument intelligence features. It is designed to help biopharma QC analysts boost efficiency and eliminate up to 40% of common errors, saving time lost by investigating the source of failed runs and out-of-specification results.
The bio-inert design of the instrument features Waters MaxPeak HPS Technology applied to key internal components including the system flow path to reduce unwanted interactions from metal-adsorbing analytes. The system pairs with Waters QuanRecovery™ Vials and Plates, as well as MaxPeak Premier HPLC Columns with eConnect™ Column Tag Technology, allowing for more confident platform methods that eliminate the need for lengthy column conditioning and method development.
"Many of the challenges that impact productivity and revenues for QC labs come from human error. We collaboratively developed the Alliance iS Bio HPLC System with our customers to address daily routine challenges and help meet more stringent and evolving compliance requirements while working to achieve shorter product release timelines," said Fraser McLeod, Vice President, General Manager, QA/QC, Waters Corporation. "We built every feature of this powerful HPLC platform, including the use of bio-inert surface technology at key sample touchpoints, with simplicity, sophistication and efficiency in mind, to help biopharma QC labs save time and money."
The Alliance iS Bio HPLC System also combines with Waters compliance-ready Empower Chromatography Software to help laboratories collect, manage, and report chromatography test results. It integrates seamlessly with Waters and third-party liquid chromatography instruments to help high-volume QC labs manage operational risk, mitigate disruptions, and increase overall productivity.
The Alliance iS Bio HPLC System is now available globally.
Additional Resources
About Waters Corporation (www.waters.com)
(NYSE:WAT), a global leader in analytical instruments and software, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, food, and environmental sciences for more than 65 years. With approximately 7,900 employees worldwide, Waters operates directly in 35 countries, including 15 manufacturing facilities, and with products available in more than 100 countries.
Waters, MaxPeak, Alliance, QuanRecovery and eConnect are trademarks of Waters Technologies Corporation.
Contact:
Kevin Kempskie
Senior Director of Public Relations
Waters Corporation
This email address is being protected from spambots. You need JavaScript enabled to view it.
+1.617.413.4333
i Estimate based on Waters market research in 2022 after surveying 56 global pharmaceutical company QC labs.
| Last Trade: | US$302.45 |
| Daily Change: | 9.55 3.26 |
| Daily Volume: | 324,307 |
| Market Cap: | US$18.000B |
August 26, 2025 August 04, 2025 June 17, 2025 | |
C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MORE
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MORE
